Mumbai, India , is rapidly emerging as a significant hub for the production of Lenacapavir Sodium API (CAS 2189684-53-3). Several companies have established robust manufacturing plants focusing on this critical antiviral drug . Identifying the absolute top manufacturers can be difficult due to fluctuating market dynamics, but reputable names often